Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy

Brain

Volumn 127, Issue 4, 2004, Pages 929-939

  Chattopadhyay, Munmun ^a   Goss, James ^a,c   Wolfe, Darren ^b   Goins, William C ^b   Huang, Shaohua ^b   Glorioso, Joseph C ^b   Mata, Marina ^a,c   Fink, David J ^a,b,c,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Gene therapy; Herpes; Nerve growth factors; Neuropathy

Indexed keywords

CISPLATIN; NERVE GROWTH FACTOR; NEUROTROPHIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN NERVE CELL; CONTROLLED STUDY; ELECTROPHYSIOLOGY; GENE DELIVERY SYSTEM; GENE TRANSFER; HERPES SIMPLEX VIRUS; HISTOLOGY; IN VIVO STUDY; INOCULATION; MALE; NEUROPATHY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL GANGLION; VIRUS REPLICATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELLS, CULTURED; CISPLATIN; GENE THERAPY; GENETIC VECTORS; MALE; NERVE GROWTH FACTORS; NEURAL CONDUCTION; NEUROPEPTIDES; PERIPHERAL NERVOUS SYSTEM DISEASES; PROPRIOCEPTION; RATS; RATS, WISTAR; SIMPLEXVIRUS;

EID: 1842683919     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh103     Document Type: Article

References (49)

1. Aloe L, Manni L, Properzi F, De Santis S, Fiore M. Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by cisplatin: behavioral, structural and biochemical analysis. Auton Neurosci 2000; 86: 84-93.
2. Apfel SC. Neurotrophic factors in peripheral neuropathies: therapeutic implications. Brain Pathol 1999; 9: 393-413.
3. Apfel SC. Neurotrophic factor therapy-prospects and problems. Clin Chem Lab Med 2001; 39: 351-5.
4. Apfel SC. Is the therapeutic application of neurotrophic factors dead? Ann Neurol 2002a; 51: 8-11.
5. Apfel SC. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold? Int Rev Neurobiol 2002b; 50: 393-413.
6. Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res 1994; 634: 7-12.
7. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 1995; 18: 223-53.
8. Cavaletti G, Cascinu S, Venturino P, Tedeschi M, Tredici G. Neuroprotectant drugs in cisplatin neurotoxicity. Anticancer Res 1996; 16: 3149-59.
9. Chattopadhyay M, Wolfe D, Huang S, Goss J, Glorioso J, Mata M, et al. In vivo gene therapy of pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3. Ann Neurol 2002; 51: 19-27.
10. Chattopadhyay M, Goss J, Lacomis D, Goins W, Glorioso JC, Mata M, et al. Protective effect of HSV-mediated gene transfer of nerve growth factor in pyridoxine neuropathy demonstrates functional activity of trkA receptors in large sensory neurons of adult animals. Eur J Neurosci 2003; 17: 732-40.
11. Cohen SM, Lippard SJ. Cisplatin: from DNA damage to cancer chemotherapy. Prog Nucleic Acid Res Mol Biol 2001; 67: 93-130.
12. DeLuca NA, McCarthy AM, Schaffer PA. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 1985; 56: 558-70.
13. Fernyhough P, Diemel LT, Hardy J, Brewster WJ, Mohiuddin L, Tomlinson DR. Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur J Neurosci 1995; 7: 1107-10.
14. Francis N, Farinas I, Brennan C, Rivas-Plata K, Backus C, Reichardt L, et al. NT-3, like NGF, is required for survival of sympathetic neurons, but not their precursors. Dev Biol 1999; 210: 411-27.
15. Gill JS, Windebank AJ. Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. J Clin Invest 1998; 101: 2842-50.
16. Goins WF, Sternberg LR, Croen KD, Krause PR, Hendricks RL, Fink DJ, et al. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol 1994; 68: 2239-52.
17. Goins WF, Lee KA, Cavalcoli JD, O'Malley ME, DeKosky ST, Fink DJ, et al. Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. J Virol 1999; 73: 519-32.
18. Goss JR, Mata M, Goins WF, Wu HH, Glorioso JC, Fink DJ. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther 2001; 8: 551-6.
19. Goss JR, Goins WF, Lacomis D, Mata M, Glorioso JC, Fink DJ. Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes 2002; 51: 2227-32.
20. Grill RJ, Blesch A, Tuszynski MH. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells. Exp Neurol 1997; 148: 444-52.
21. Hao S, Mata M, Goins W, Glorioso JC, Fink DJ. Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain. Pain 2003; 102: 135-142.
22. Harrison SM, Jones ME, Uecker S, Albers KM, Kudrycki KE, Davis BM. Levels of nerve growth factor and neurotrophin-3 are affected differentially by the presence of p75 in sympathetic neurons in vivo. J Comp Neurol 2000; 424: 99-110.
23. High KA. Gene transfer as an approach to treating hemophilia. Semin Thromb Hemost 2003; 29: 107-20.
24. Ishii DN, Lupien SB. Insulin-like growth factors protect against diabetic neuropathy: effects on sensory nerve regeneration in rats. J Neurosci Res 1995; 40: 138-44.
25. Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 2000; 10: 381-91.
26. Krisky DM, Marconi PC, Oligino T, Rouse RJ, Fink DJ, Glorioso JC. Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther 1997; 4: 1120-5.
27. McDonald ES, Windebank AJ. Cisplatin-induced apoptosis of DRG neurons involves bax redistribution and cytochrome c release but not fas receptor signaling. Neurobiol Dis 2002; 9: 220-33.
28. McKeage MJ, Hsu T, Screnci D, Haddad G, Baguley BC. Nucleolar damage correlates with neurotoxicity induced by different platinum drugs. Br J Cancer 2001; 85: 1219-25.
29. Meijer C, de Vries EG, Marmiroli P, Tredici G, Frattola L, Cavaletti G. Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy. Neurotoxicology 1999; 20: 883-7.
30. Ojala PM, Sodeik B, Ebersold MW, Kutay U, Helenius A. Herpes simplex virus type 1 entry into host cells: reconstitution of capsid binding and uncoating at the nuclear pore complex in vitro. Mol Cell Biol 2000; 20: 4922-31.
31. Ozuer A, Wechuck JB, Russell B, Wolfe D, Goins WF, Glorioso JC, et al. Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors. Biotechnol Prog 2002; 18: 476-82.
32. Peltier AC, Russell JW. Recent advances in drug-induced neuropathies. Curr Opin Neurol 2002; 15: 633-8.
33. Pradat PF, Finiels F, Kennel P, Naimi S, Orsini C, Delaere P, et al. Partial prevention of cisplatin-induced neuropathy by electroporation-mediated nonviral gene transfer. Hum Gene Ther 2001a; 12: 367-75.
34. Pradat PF, Kennel P, Naimi-Sadaoui S, Finiels F, Orsini C, Revah F, et al. Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies. Hum Gene Ther 2001b; 12: 2237-49.
35. Pradat PF, Kennel P, Naimi-Sadaoui S, Finiels F, Scherman D, Orsini C, et al. Viral and non-viral gene therapy partially prevents experimental cisplatin-induced neuropathy. Gene Ther 2002; 9: 1333-7.
36. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol 2002; 249: 9-17.
37. Roizman B, Sears A. Herpes simplex viruses and their replication. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Hirsch MS, Melnick JL, et al., editors. Fields virology, Vol. 2. 3rd edn. Philadelphia (PA): Lippincott-Raven; 1996. p. 2231-95.
38. Samaniego LA, Neiderhiser L, DeLuca NA. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J Virol 1998; 72: 3307-20.
39. Shibata M, Murray M, Tessler A, Ljubetic C, Connors T, Saavedra RA. Single injections of a DNA plasmid that contains the human Bcl-2 gene prevent loss and atrophy of distinct neuronal populations after spinal cord injury in adult rats. Neurorehabil Neural Repair 2000; 14: 319-30.
40. Shukla D, Spear PG. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J Clin Invest 2001; 108: 503-10.
41. Smith GA, Gross SP, Enquist LW. Herpesviruses use bidirectional fast-axonal transport to spread in sensory neurons. Proc Natl Acad Sci USA 2001; 98: 3466-70.
42. Spear PG, Eisenberg RJ, Cohen GH. Three classes of cell surface receptors for alphaherpesvirus entry. Virology 2000; 275: 1-8.
43. Steiner I, Kennedy PG. Herpes simplex virus latent infection in the nervous system. J Neurovirol 1995; 1: 19-29.
44. Tessarollo L, Tsoulfas P, Donovan MJ, Palko ME, Blair-Flynn J, Hempstead BL, et al. Targeted deletion of all isoforms of the trkC gene suggests the use of alternate receptors by its ligand neurotrophin-3 in neuronal development and implicates trkC in normal cardiogenesis. Proc Natl Acad Sci USA 1997; 94: 14776-81.
45. Thoenen H, Sendtner M. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat Neurosci 2002; 5 Suppl: 1046-50.
46. Verdu E, Vilches JJ, Rodriguez FJ, Ceballos D, Valero A, Navarro X. Physiological and immunohistochemical characterization of cisplatin-induced neuropathy in mice. Muscle Nerve 1999; 22: 329-40.
47. Ye GJ, Vaughan KT, Vallee RB, Roizman B. The herpes simplex virus 1 U(L)34 protein interacts with a cytoplasmic dynein intermediate chain and targets nuclear membrane. J Virol 2000; 74: 1355-63.
48. Zhang Y, Dijkhuizen PA, Anderson PN, Lieberman AR, Verhaagen J. NT-3 delivered by an adenoviral vector induces injured dorsal root axons to regenerate into the spinal cord of adult rats. J Neurosci Res 1998; 54: 554-62.
49. Zhuang HX, Snyder CK, Pu SF, Ishii DN. Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats. Exp Neurol 1996; 140: 198-205.